Suxamethonium--a review. II. Neuromuscular blocking properties.
D000136:Acid-Base Equilibrium; D000200:Action Potentials; D000328:Adult; D000777:Anesthetics / Q000494:pharmacology; D001049:Apnea / Q000139:chemically induced; D003650:Decamethonium Compounds / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008564:Membrane Potentials; D009132:Muscles / Q000378:metabolism; D009467:Neuromuscular Depolarizing Agents / Q000494:pharmacology; D009469:Neuromuscular Junction / Q000187:drug effects; D003473:Neuromuscular Nondepolarizing Agents / Q000494:pharmacology; D010101:Oxygen Consumption / Q000187:drug effects; D010146:Pain / Q000209:etiology; D013390:Succinylcholine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D013696:Temperature; D014882:Water-Electrolyte Balance
D000777:Anesthetics; D003650:Decamethonium Compounds; D009467:Neuromuscular Depolarizing Agents; D003473:Neuromuscular Nondepolarizing Agents; D013390:Succinylcholine